According to the molecular classification of breast cancer, the clinical therapeutic strategy is formulated. Currently, the diagnostic value of amide proton transfer (APT) imaging in breast cancer is still unclear. This study aims to explore the diagnostic value of APT, DWI, and DCE-MRI in the molecular classification and prognosis of breast cancer. Our results showed that there were differences in TTP and BE values between luminal and non-luminal subtypes of breast cancer. The combination of APT, DWI, and DCE-MRI had the highest diagnostic efficiency. APT, DWI, and DCE-MRI parameters were correlated with different prognostic factors of breast cancer.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: